DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 251-256

  Woodcock, D M ^a   Linsenmeyer, M E ^a   Doherty, J P ^a   Warren, W D ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Breast tumour; CpG island; DNA methylation; Genomic sequencing; p16; SP1 sites

Indexed keywords

DNA; PROTEIN P16;

ARTICLE; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0032894267     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690041     Document Type: Article

References (35)

1. Antequera F, Boyes J and Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-514
2. Baylin SB (1992) Abnormal regional hypermethylation in cancer cells. Aids Res Hum Retroviruses 8: 811-820
3. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A and Cedar H (1994) Spl elements protect a CpG island from de novo methylation. Nature 371: 435-438
4. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5924-5929
5. Clark SJ, Harrison J and Frommer M (1995) CpNpG methylation in mammalian cells. Nature Genet 10: 20-27
6. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831
7. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867
8. Harrington MA, Jones PA, Imagawa M and Karin M (1988) Cytosine methylation does not affect binding of transcription factor Spl. Proc Natl Acad Sci USA 85: 2066-2070
9. Herman JG, Jen J, Merlo A and Baylin SB (1996a) Hypermethylation-associated inactivation indicates a tumour suppressor role for p15INK4B1. Cancer Res 56: 722-727
10. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB (1996b) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
11. Holliday R and Pugh JE (1975) DNA modification mechanisms and gene activity during development. Science 187: 226-232
12. Kamb A (1995) Cell cycle regulators and cancer. Trends Genet 11: 136-140
13. Klimasauskas S and Roberts RJ (1995) Disruption of the target G C base-pair by the Hhal methyltransferase. Gene 157: 163-164
14. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
15. Laayoun A and Smith SS (1995) Methylation of slipped duplexes, snapbacks and cruciforms by human DNA(cytosine-5)methyltransferase. Nucleic Acids Res 23: 1584-1589
16. Lei H, Oh SP, Okano M, Jutterman R, Goss KA, Jaenisch R and Li E (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122: 3195-3205
17. Macleod D, Charlton J, Mullins J and Bird AP (1994) Spl sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 8: 2282-2292
18. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D (1995) A novel p16INK4A transcript. Cancer Res 55: 2995-2997
19. Merchant JL, Demediuk B and Brand SJ (1991) A GC-rich element confers epidermal growth factor responsiveness to transcription from the gastrin promoter. Mol Cell Biol 11: 2686-2696
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSI in human cancers. Nature Med 1: 686-692
21. Minth CD and Dixon JE (1990) Expression of the human neuropeptide Y gene. J Biol Chem 265: 12933-12939
22. Monk M (1990) Changes in DNA methylation during mouse embryonic development in relation to X-chromosome activity and imprinting. Philos Trans R Soc Lond B Biol Sci 326: 299-312
23. Riggs AD (1975) X-inactivation, differentiation and DNA methylation. Cytogenet Cell Genet 14: 9-25
24. Silke J, Rother KI, Georgiev O, Schaffner W and Matsuo K (1995) Complex demethylation patterns at Spl binding sites in F9 embryonal carcinoma cells. FEBS Lett 370: 170-174
25. Smith SS, Lingeman RG and Kaplan BE (1992) Recognition of foldback DNA by the human DNA (cytosine-5-)-methyltransferase. Biochemistry 31: 850-854
26. Snibson KJ, Woodcock DM, Orian JM, Brandon MR and Adams TE (1995) Methylation and expression of a metallothionein promoter ovine growth hormone fusion gene (MT0GH1) in transgenic mice. Transgenic Res 4: 114-122
27. Strauss BS (1991) The 'A rule' of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? Bioessays 13: 79-84
28. Szyf M (1994) DNA methylation properties: consequences for pharmacology. Trends Pharmacol Sci 15: 233-238
29. Thiesen H-J and Bach C (1990) Target detection assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. Nucleic Acids Res 18: 3203-3209
30. Toth M, Müller U and Doerfler W (1990) Establishment of de novo DNA methylation patterns: transcription factor binding and deoxycytidine methylation at CpG anf non-CpG sequences in an integrated adenovirus promoter. J Mol Biol 214: 673-683
31. Tucker KL, Beard C, Dausman J, Jackson-Grusby L, Laird PW, Lei H, Li E and Jaenisch R (1996) Germline passage is required for establishment of methylation and expression of imprinted but not of nonimprinted genes. Genes Dev 10: 1008-1020
32. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, Riggs AD and Orkin SH (1987) Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47: 4806-4813
33. Woodcock D, Crowther P and Diver W (1987) The majority of methylated deoxycytidines in human DNA are not in the CpG dinucleotide. Biochem Biophys Res Commun 145: 888-894
34. Woodcock DM, Lawler CB, Linsenmeyer ME and Warren WD (1997) Asymmetric methylation in the hyper-methylated CpG promoter region of the human LI retrotransposon. J Biol Chem 272: 7810-7816
35. Woodcock DM, Linsenmeyer ME and Warren WD (1998) DNA methylation in mouse A-repeats in DNA methyltransferase-knockout ES cells and in normal cells determined by bisulphite genomic sequencing. Gene 206: 63-67